Zobrazeno 1 - 4
of 4
pro vyhledávání: '"N. R. Ramer"'
Autor:
C. W. Hanson, D. T. W. Chu, N. R. Ramer, Robert R. Bower, R N Swanson, P B Fernandes, John M. Stamm, Dwight J. Hardy
Publikováno v:
Antimicrobial Agents and Chemotherapy. 32:27-32
A-61827 (A-60969 is the hydrochloric salt of A-61827) is a new aryl-fluoronaphthyridine which is active against aerobic and anaerobic bacteria. The MICs of A-61827 for 90% of strains (MIC90) of staphylococci and streptococci were less than or equal t
Autor:
K. P. Jarvis, N. R. Ramer, Robert R. Bower, P B Fernandes, D. T. W. Chu, Nathan L. Shipkowitz
Publikováno v:
Antimicrobial Agents and Chemotherapy. 29:201-208
A-56619 and A-56620 are two new aryl-fluoroquinolones which are as potent as or more potent than norfloxacin when administered orally and subcutaneously in mouse protection tests against Staphylococcus aureus, Streptococcus pyogenes, and Streptococcu
Autor:
N. R. Ramer, J Pintar, Dwight J. Hardy, R N Swanson, R Bailer, E J McDonald, E Gade, P B Fernandes
There is poor correlation between the MICs and zone sizes obtained for erythromycin against Haemophilus influenzae. The effect of two media, Mueller-Hinton medium supplemented with 3% lysed horse blood and 10 micrograms of NAD per ml (MHA + LYHB) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::785976447b2fe37a09bf3b1ef522eae3
https://europepmc.org/articles/PMC174912/
https://europepmc.org/articles/PMC174912/
Autor:
P B Fernandes, N. R. Ramer, Dwight J. Hardy, E J McDonald, E Gade, Robert R. Bower, C. W. Hanson, Nathan L. Shipkowitz, R N Swanson, R Bailer
Publikováno v:
Antimicrobial agents and chemotherapy. 30(6)
The in vitro and in vivo antibacterial activity of A-56268 (TE-031), the 6-O-methyl derivative of erythromycin, was compared with those of erythromycin and other reference drugs. A-56268 had the same spectrum of antibacterial activity as erythromycin